These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3010486)

  • 41. Effects of sodium depletion on tissue concentrations of the natriuretic hormone vasoactive intestinal peptide.
    Duggan KA; Ye VZ
    Clin Exp Pharmacol Physiol; 1995 Aug; 22(8):583-4. PubMed ID: 7586717
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparison of 99mTc-DTPA and 113mIn-DTPA aerosol clearances in humans. Effects of smoking, hyperinflation, and in vitro oxidation.
    Nolop KB; Maxwell DL; Fleming JS; Braude S; Hughes JM; Royston D
    Am Rev Respir Dis; 1987 Nov; 136(5):1112-6. PubMed ID: 3314610
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of electroacupuncture of "Chize" (LU 5) and "Shangjuxu" (ST 37) on mesenteric microcirculation and vasoactive intestinal peptide levels in the lung, colon and hypothalamus in rats with chronic obstructive pulmonary diseases].
    Yang WN; Li ZT; Xie JP; Li SJ; Zhao YF
    Zhen Ci Yan Jiu; 2012 Oct; 37(5):369-74. PubMed ID: 23342775
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ontogenic development of vasoactive intestinal peptide receptors in rat intestinal cells and liver.
    Chastre E; Emami S; Rosselin G; Gespach C
    Endocrinology; 1987 Dec; 121(6):2211-21. PubMed ID: 2824182
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The relation of vasoactive intestinal peptide and acute hypoxia].
    Li X; Lu WC; Zhu YJ
    Zhonghua Nei Ke Za Zhi; 1990 Jan; 29(1):8-10, 59. PubMed ID: 2401169
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vasoactive intestinal peptide in man: pharmacokinetics, metabolic and circulatory effects.
    Domschke S; Domschke W; Bloom SR; Mitznegg P; Mitchell SJ; Lux G; Strunz U
    Gut; 1978 Nov; 19(11):1049-53. PubMed ID: 730072
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Accelerated clearance of small solutes from the lungs in interstitial lung disease.
    Rinderknecht J; Shapiro L; Krauthammer M; Taplin G; Wasserman K; Uszler JM; Effros RM
    Am Rev Respir Dis; 1980 Jan; 121(1):105-17. PubMed ID: 7352693
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dose- and time-dependent effects of lipopolysaccharide on technetium-99-m-labeled diethylene-triamine pentaacetatic acid clearance, respiratory system mechanics and pulmonary inflammation.
    Kastis GA; Toumpanakis D; Loverdos K; Anaplioti A; Samartzis A; Argyriou P; Loudos G; Karavana V; Tzouda V; Datseris I; Rontogianni D; Roussos C; Theocharis SE; Vassilakopoulos T
    Exp Biol Med (Maywood); 2013 Feb; 238(2):209-22. PubMed ID: 23576803
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Early effects of inhaled Ca-DTPA on the rat lung.
    Smith VH; Dagle GE; Gelman RA; Ragan HA
    Toxicol Lett; 1980 Nov; 7(1):9-16. PubMed ID: 7292518
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel concepts of neuropeptide-based drug therapy: vasoactive intestinal polypeptide and its receptors.
    Groneberg DA; Rabe KF; Fischer A
    Eur J Pharmacol; 2006 Mar; 533(1-3):182-94. PubMed ID: 16473346
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Relevance of vasoactive intestinal peptide and total bronchial mucin in rat lung.].
    Li X; Wang XM; Zhang JS
    Sheng Li Xue Bao; 2009 Dec; 61(6):539-43. PubMed ID: 20029687
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Substance P and vasoactive intestinal polypeptide in the streptozotocin-induced diabetic rat retina.
    Troger J; Neyer S; Heufler C; Huemer H; Schmid E; Griesser U; Kralinger M; Kremser B; Baldissera I; Kieselbach G
    Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):1045-50. PubMed ID: 11274084
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clearance of inhaled 99mTc DTPA from regions of the lung recently affected by pulmonary embolus.
    Buxton-Thomas M; Higenbottam T; Barber R; Wraight P
    Bull Eur Physiopathol Respir; 1986; 22(1):55-60. PubMed ID: 3516268
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characteristics of pertechnetate movement across the canine tracheal epithelium.
    Man SF; Ahmed IH; Man GC; Nguyen A
    Am Rev Respir Dis; 1985 Jan; 131(1):90-3. PubMed ID: 2981492
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lung clearance of soluble radioaerosols of different molecular weights in systemic sclerosis.
    Chopra SK; Taplin GV; Tashkin DP; Elam D
    Thorax; 1979 Feb; 34(1):63-7. PubMed ID: 442001
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Elcatonin raises levels of vasoactive intestinal peptide in human plasma.
    Takeyama M; Ikawa K; Nagano T; Mori K
    J Pharm Pharmacol; 1996 Jun; 48(6):657-9. PubMed ID: 8832504
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neurotensin and vasoactive intestinal peptide levels during orthotopic liver transplantation in man.
    Khoury GF; Kaufman RD; Musich J; Mogard M
    Transplantation; 1988 Oct; 46(4):601-2. PubMed ID: 3051571
    [No Abstract]   [Full Text] [Related]  

  • 58. Early increase of vasoactive intestinal peptide in acute myocardial infarction.
    Lucia P; Caiola S; Coppola A; Maroccia E; Belli M; Buongiorno A; De Martinis C
    Am Heart J; 1996 Jul; 132(1 Pt 1):187-9. PubMed ID: 8701862
    [No Abstract]   [Full Text] [Related]  

  • 59. Vasoactive intestinal peptide and nitric oxide (NO) in the acute phase following burns and trauma.
    Harper R; Martin R
    Burns; 2002 May; 28(3):288; author reply 289. PubMed ID: 11996867
    [No Abstract]   [Full Text] [Related]  

  • 60. Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications.
    Labiris NR; Dolovich MB
    Br J Clin Pharmacol; 2003 Dec; 56(6):588-99. PubMed ID: 14616418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.